Insmed INSM
NASDAQ INSM
$126.10 -0.58 (-0.46%)
As of: Sep 4, 2026 · 2:22 PM EDT

Insmed (INSM) EPS (Basic) Growth (5y) (2015 - 2026)

Analysis

Insmed (INSM) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Incyte 25.64 Bn 21.11 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.61%
Mar 31, 2026 3.12%
Dec 31, 2025 -9.53%
Sep 30, 2025 -22.77%
Jun 30, 2025 -21.56%
Mar 31, 2025 -13.93%
Dec 31, 2024 -18.04%
Sep 30, 2024 -13.30%
Jun 30, 2024 -19.04%
Mar 31, 2024 -2.04%
Dec 31, 2023 -2.15%
Sep 30, 2023 0.47%
Jun 30, 2023 -12.32%
Mar 31, 2023 -5.55%
Dec 31, 2022 -5.79%
Sep 30, 2022 -9.43%
Jun 30, 2022 -2.18%
Mar 31, 2022 -5.70%
Dec 31, 2021 1.83%
Sep 30, 2021 -9.54%